TFXTFXHealthcare · Medical Instruments & Supplies

TFX Stock Forecast: Teleflex, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$162
−1.14% on the day

The 12 Wall Street analysts covering Teleflex, Inc. hold a median 12-month price target of $169 — +4.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 93 of 100 as at 21 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$6.5B
Ticker Nerd rank
93/ 100
Median analyst target
$169
Analysts covering
12
Revenue$570.3M−27.0% y/y
Operating income$73.1M
Net income$99.7M
Free cash flow$80.3M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+4.4%
1M
+23.4%
YTD
+33.7%
1Y
+55.9%
From 52W high
−2.6%
From 52W low
+62.6%
$99
$166
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Teleflex, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
93/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
100
Value
91
Volatility
91
Accruals
88
Momentum
77
Revisions
72
Growth
56
Quality
49

Issuance (100): The share count has been shrinking and the company is not leaning on new borrowing.

Quality (49): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

TFX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on TFX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$120$140$160$180Jan 26Apr 26Jul 26Oct 26TFXHigh $178Median $169Low $158

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says12 analysts
6
Buy
6
Hold
0
Sell
$158
Low
$169
Median
$178
High

The green dot is the last close — the median target sits +4.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 10 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
9 Nov 2026Truist SecuritiesMaintainsHold$142 → $167
6 Nov 2026RBC CapitalMaintainsOutperform$155 → $175
6 Nov 2026Wells FargoMaintainsEqual-Weight$138 → $167
14 Oct 2026Truist SecuritiesMaintainsHold$150 → $142
28 Sept 2026B of A SecuritiesUpgradeBuy$145 → $158
25 Aug 2026NeedhamMaintainsBuy$159 → $170
11 Aug 2026UBSMaintainsNeutral$145 → $158
10 Aug 2026Truist SecuritiesMaintainsHold$143 → $150
7 Aug 2026Piper SandlerReiteratesOverweight$160 → $169
31 July 2026NeedhamMaintainsBuy$147 → $159
28 July 2026UBSInitiatesNeutral$145
15 July 2026MizuhoMaintainsNeutral$140 → $145
9 July 2026BMO CapitalInitiatesOutperform$159
8 June 2026Piper SandlerUpgradeOverweight—
11 May 2026Truist SecuritiesReiteratesHold—
8 May 2026RBC CapitalUpgradeOutperform—
8 May 2026Wells FargoMaintainsEqual-Weight—
27 Mar 2026Raymond JamesUpgradeOutperform—
27 Feb 2026RBC CapitalMaintainsSector Perform—
27 Feb 2026Wells FargoMaintainsEqual-Weight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for TFX.

Market Radar

This page is one stock. Monday covers all of them.

TFX appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

TFX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Teleflex, Inc. returned +55.9% against +6.9% for the S&P 500, dividends included.

TFX vs S&P 500, last 12 monthsTotal return, rebased to 100
100120140160Jan 26Apr 26Jul 26Oct 26TFXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

TFX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+8.5%
Analysts raising
6
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
81.6×

Cheaper than 10% of US stocks

Price / sales
2.9×

Cheaper than 38% of US stocks

Price / book
1.9×

Cheaper than 45% of US stocks

EV / EBITDA
16.4×

Cheaper than 29% of US stocks

Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
58.2%

Higher than 71% of US stocks

Operating margin
11.7%

Higher than 66% of US stocks

Net margin
—
Returns & dividend
Return on equity
2.4%

Higher than 48% of US stocks

Return on assets
2.3%

Higher than 60% of US stocks

Dividend yield
0.8%

Higher than 16% of US dividend payers

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Teleflex, Inc. has a market value of $6.5B and an enterprise value of $7.7B.

  • Revenue in the twelve months to 30 June 2026: $1.6B. The latest quarter shrank 27.0% year on year.

  • Net income over the same four quarters: −$1.0B, a −63.3% net margin.

  • Diluted earnings per share, trailing twelve months: −$23.29.

  • Free cash flow in the twelve months to 30 June 2026: $327.1M, after $76.1M of capital spending.

  • Teleflex, Inc. spent $250.0M on share buybacks and $59.9M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 42.4M.

  • Trailing P/E: 81.6×; forward P/E: 15.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.83%, paying out 67% of earnings.

  • Teleflex, Inc. employs 15,500 people — $105K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

TFX and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
TFXTeleflex, Inc.$6.5B93
BLCOBausch + Lomb Corp.$6.9B99
MMSIMerit Medical Systems, Inc.$5.0B86
MMEDMiniMed Group, Inc.$4.5B1
ATRAptarGroup, Inc.$9.2B62
STVNStevanato Group SpA$4.3B59
ICUIICU Medical, Inc.$4.3B95

Take a look at TFX’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Teleflex, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about TFX

What is the TFX stock price forecast for 2026-2027?

The 12 Wall Street analysts covering Teleflex, Inc. have a median 12-month price target of $169, with estimates ranging from $158 to $178. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is TFX stock a buy right now?

Of the 12 analysts covering Teleflex, Inc., 6 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Teleflex, Inc. 93 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank TFX?

As at 21 Nov 2026, Teleflex, Inc. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Issuance (100 of 100).

Will TFX stock go up?

No one can know that. What the data says: the median 12-month target from 12 analysts implies +4.6% from the last close, and Ticker Nerd's factor model ranks Teleflex, Inc. 93 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the TFX stock forecast for 2030?

No analyst covering Teleflex, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TFX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $158 to $178 over the next 12 months.

How has TFX stock performed over the past year?

Teleflex, Inc. returned +55.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Teleflex, Inc. do?

Teleflex Incorporated is a global medical technology company that designs, develops, manufactures, and supplies single-use devices used in critical care, surgery, and other hospital procedures. Teleflex Incorporated’s portfolio spans vascular access, anesthesia, emergency medicine, interventional cardiology and radiology, surgical applications, respiratory care, and urology, serving hospitals, healthcare providers, and medical device partners.

Company

About Teleflex, Inc.

Teleflex Incorporated is a global medical technology company that designs, develops, manufactures, and supplies single-use devices used in critical care, surgery, and other hospital procedures. Teleflex Incorporated’s portfolio spans vascular access, anesthesia, emergency medicine, interventional cardiology and radiology, surgical applications, respiratory care, and urology, serving hospitals, healthcare providers, and medical device partners. The company also provides original equipment manufacturing services, supporting other medical device makers with components and specialized products. Its offerings are used in diagnostic and therapeutic procedures that require reliable, procedure-focused tools across a broad range of clinical settings. Headquartered in Wayne, Pennsylvania and founded in 1943, Teleflex Incorporated operates as a diversified healthcare equipment provider with a strong presence across the Americas, EMEA, and Asia.

CEO Mr. Jason Weidman · 15,500 employees · United States · https://www.teleflex.com